OR WAIT null SECS
August 02, 2022
CRYOPDP is expanding its footprint to Spain with its acquisition of Polar Expres.
Novasep-PharmaZell will increase API production capacity at its Mourenx site with €7.3M investment.
Pharma’s leveraging real-world evidence to drive product approval, reimbursement, and market access.
GSK has completed its demerger of Haleon and has signed an agreement to help support future pandemic preparedness in Europe.
August 01, 2022
The European Commission has approved Rinvoq (upadacitinib) for treatment of active non-radiographic axial spondyloarthritis.
The European Commission has granted marketing authorization to Upstaza (eladocagene exuparvovec) for treatment of aromatic L-amino acid decarboxylase (AADC) deficiency.
July 26, 2022
AstraZeneca's acquisition of TeneoTwo will give the company access to its clinical-stage T-cell engager, TNB-486, strengthening their hematological cancer pipeline.
July 25, 2022
WHO has determined that monkeypox constitutes a public health emergency of international concern.
Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer.
The agency’s human medicines committee recommended drugs to treat breast cancer, lupus nephritis, type 2 diabetes and more.